Join to View Full Profile
21 Donald B Dean DrivePortland, ME 04106
Phone+1 207-518-6600
Fax+1 207-541-5449
Dr. Scoll is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin Scoll is a urologist based in Portland, ME. He completed his medical education and residencies in surgery and urology at Temple University and its affiliated hospitals, including the Fox Chase Cancer Center. His practice focuses on general adult urology, including BPH, kidney stones, vasectomy, and urologic cancer screening and treatment.
Education & Training
Temple University HospitalResidency, Urology, 2006 - 2010- Temple University HospitalResidency, Surgery, 2004 - 2006
Lewis Katz School of Medicine at Temple UniversityClass of 2004
Certifications & Licensure
ME State Medical License 2010 - 2028
PA State Medical License 2004 - 2010
American Board of Urology Urology
Awards, Honors, & Recognition
- Emerging Leader Award Lewis Katz School of Medicine at Temple University, 2019
- CMS Meaningful Use Stage 1 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification athenaClinicals, athenahealth, Inc., 2014, 2016-2017
Publications & Presentations
PubMed
- 65 citationsMulti-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.Jamie Messer, John D. Terrell, Michael Herman, Casey K. Ng, Douglas S. Scherr
Urologic Oncology. 2013-08-01 - 67 citationsHigh-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical ResectionThomas Clements, Jamie Messer, John D. Terrell, Michael Herman, Casey K. Ng
Journal of Endourology. 2012-04-05 - 181 citationsUrinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.Jamie Messer, Shahrokh F. Shariat, James C. Brien, Michael Herman, Casey K. Ng
BJU International. 2011-09-01
Press Mentions
2019 Alumni Award RecipientsApril 2nd, 2020
Professional Memberships
- Member
External Links
- Fore River Urologyhttp://www.frurology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
